Is CANC stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Tema Oncology ETF pays dividends. Last time was Friday 15th of December 2023 where the investors holding the stock on Wednesday 13th of December 2023 were paid $0.14911 per share. Over the last 1 times between 2023 and 2023, Tema Oncology ETF has paid $0.14911 with an average of $0.15 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Tema Oncology ETF 10 years ago, but if you had invested on Monday 14th of August 2023 when the price was $3.64, you would have made a profit of $24.83 per share or 682.14%
No, the average daily trading liquidity for Tema Oncology ETF is $365 190 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Tema Oncology ETF has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Tema Oncology ETF to be low [0 out of 1]